S, M., C, R., M, L., I, S., & V, J. (2021). Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions. Clinical pharmacokinetics, 60(4), 409. https://doi.org/10.1007/s40262-020-00981-0
Chicago Style (17th ed.) CitationS, Magréault, Roy C, Launay M, Sermet-Gaudelus I, and Jullien V. "Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions." Clinical Pharmacokinetics 60, no. 4 (2021): 409. https://doi.org/10.1007/s40262-020-00981-0.
MLA (9th ed.) CitationS, Magréault, et al. "Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions." Clinical Pharmacokinetics, vol. 60, no. 4, 2021, p. 409, https://doi.org/10.1007/s40262-020-00981-0.